Skip to main content

Advertisement

SpringerLink
Log in

Response to letter to the editor referencing manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Argyriou AA, Chroni E, Koutras A et al (2006) A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14:1134–1140

    Article  PubMed  Google Scholar 

  2. Argyriou AA, Chroni E, Koutras A et al (2006) Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 32:237–244

    Article  PubMed  CAS  Google Scholar 

  3. Pace A, Giannarelli D, Galie E et al (2010) Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology 74:762–766

    Article  PubMed  CAS  Google Scholar 

  4. Sloan JA, Berk L, Roscoe J et al (2007) Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 25:5070–5077

    Article  PubMed  Google Scholar 

  5. Morton RF, Sloan JA, Grothey A et al (2005) A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. J Clin Oncol 23:750s

    Google Scholar 

  6. Huschka MM, Mandrekar SJ, Schaefer PL et al (2007) A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer 109:787–795

    Article  PubMed  Google Scholar 

  7. Grothey A, Nikcevich DA, Sloan JA et al (2010) Intravenous calcium and magnesium prevents oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol (in press)

Download references

Conflict Statement

None.

Author information

Authors and Affiliations

  1. Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA

    Lisa A. Kottschade, Jeff A. Sloan & Charles L. Loprinzi

Authors
  1. Lisa A. Kottschade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeff A. Sloan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles L. Loprinzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa A. Kottschade.

Additional information

This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35113, and 124477.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kottschade, L.A., Sloan, J.A. & Loprinzi, C.L. Response to letter to the editor referencing manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”. Support Care Cancer 19, 727–728 (2011). https://doi.org/10.1007/s00520-011-1103-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1103-2

Keywords

Search

Navigation